The DLL3 gene helps guide early development of the spine and ribs by supporting the timing signals that tell growing tissues how to form in an orderly pattern. If it does not work properly, a person may be born with vertebrae and ribs that formed differently, which can lead to scoliosis, a short trunk, and sometimes breathing problems. This gene plays an important role in a rare inherited condition called spondylocostal dysostosis.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do the work. Other genes mainly help determine when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
DLL3Gene function
What if the gene works
The DLL3 gene helps control Notch signaling, a cell communication system. During early development, it supports the orderly formation of the spine and ribs.
Risk
What if the gene does not work
More disruptive variants in the DLL3 gene can cause a condition affecting spine and rib development, often with vertebrae and rib differences, scoliosis, and short trunk short stature. Milder variants may lead to a broader range of features and severity.
Treatment
What does that mean for your treatment
No DLL3-specific treatment or management approach is currently established for pathogenic variants in the DLL3 gene. Separately, the DLL3 gene is being studied as a drug target in some neuroendocrine cancers, especially small cell lung cancer.
Conditions associated with DLL3
Gene function
What if the gene works
Early in pregnancy, the DLL3 gene helps an embryo build the body in an orderly pattern. Its main role is to tune Notch signals, which are messages cells use to coordinate timing and shape. Most of this work happens inside cells, which is a key part of how the DLL3 gene works during early development.
The DLL3 gene fine tunes Notch signaling during early development. This helps cells follow the right timing cues as body segments begin to form.
Inside cells, this gene helps manage Notch related proteins in the Golgi (the cell's protein sorting area). This keeps key signaling parts in the right place at the right stage of development.
The DLL3 gene supports somite formation (the repeating tissue blocks that later help shape the spine and ribs). This orderly timing helps the growing embryo build a balanced body plan.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DLL3 gene can change how the DLL3 protein is built, folded, or moved inside developing cells, which helps explain DLL3 gene variant effects on spine formation. More disruptive variants may stop the protein from being made at all or leave it too short to work, while some missense variants change a single building block and may leave partial activity. This range can influence how strongly cell-to-cell signaling is disturbed and, in DLL3-related conditions, how marked skeletal changes are.
How variants are linked to conditions
Pathogenic variants in the DLL3 gene are linked to DLL3-related spondylocostal dysostosis, a condition that affects how the spine and ribs form before birth. This diagnosis is typically confirmed when a person has disease-causing variants in both copies of the DLL3 gene. People with this condition may have a short trunk, an uneven chest shape, spinal curvature, and in some cases breathing problems related to rib and chest development.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For DLL3, risk is mainly shaped by inheritance, not by lifestyle. If both parents carry a harmful change in the DLL3 gene, each pregnancy has a 1 in 4, or 25%, chance of a child being born with the related bone growth condition. There is not enough evidence to say that diet, exercise, or other everyday factors lower this risk.
Inheritance of DLL3 variants
DLL3-related conditions are inherited in an autosomal recessive pattern. This means a child inherits one altered copy of the DLL3 gene from each parent, and both parents are usually healthy carriers. When both parents carry a DLL3 variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy. In practical terms, the DLL3 inheritance pattern affects sons and daughters equally, and carriers can pass the variant to children even if they have no symptoms themselves.
What does my DLL3 result mean for my family?
For families with a disease-causing change in the DLL3 gene, the pattern is usually recessive, which often means both parents are healthy carriers. Brothers and sisters may also be carriers, and in some families a sibling may be born with the same spine and rib condition linked to DLL3. Close relatives may also carry the family’s gene change.
Genetic information
Genetic testing
How you find out about variants
Variants in the DLL3 gene are found with DLL3 genetic testing, which usually uses a blood or saliva sample. A lab reads the DNA code in the DLL3 gene and checks for changes linked to inherited conditions. Results may show a pathogenic variant, a benign variant, or a variant that needs more interpretation.
When should I consider getting a genetic test?
Genetic testing for the DLL3 gene may be worth considering when a baby or child has unusual development of the spine and ribs, before birth or after delivery, because harmful changes in DLL3 can cause an inherited bone-growth condition. It can also help clarify risk when this condition runs in the family or after one affected pregnancy.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal depends on the condition and on the kind of variant involved. Over time, many factors affect how the body functions, including lifestyle, environment, age, and medical history. With some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, it may provide a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body responds to medicines. Small differences in genes can affect how a drug is broken down, how strongly it acts in the body, or how likely side effects are. This helps explain why the same treatment works well for some people, works less well for others, or feels harder to tolerate even at the same standard dose.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medicines. It studies the relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes influence both how the body handles a drug and how strong its effects may be. This information can support more informed and individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the DLL3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dosing, so general questions about symptoms, treatment, or side effects are best discussed with your doctor. They can review your health history and current medicines and decide whether anything needs a closer look.
History
The DLL3 gene entered the scientific literature in the late 1990s during studies of early embryo development and the Delta family of genes. Researchers soon connected DLL3 to the formation of the spine and ribs in animal models, which made it important in developmental genetics. From these first observations, research expanded steadily. In the early 2000s, pathogenic variants in the DLL3 gene were identified in some people with spondylocostal dysostosis, helping explain an inherited pattern of segmented spine and rib changes. In the 2010s, interest grew again when DLL3 became a focus in small cell lung cancer research, especially as a possible marker for targeted treatment development.